Ignite Creation Date:
2024-05-06 @ 6:20 PM
Last Modification Date:
2024-10-26 @ 2:45 PM
Study NCT ID:
NCT05622591
Status:
WITHDRAWN
Last Update Posted:
2023-12-08
First Post:
2022-11-08
Brief Title:
ELU001 in Pediatric Subjects Who Have Relapsed andor Refractory CBFA2T3-GLIS2-positive AML
Sponsor:
Elucida Oncology
Organization:
Elucida Oncology
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-04
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-08
First Submit QC Date:
November 14 2022
Study First Post Date:
2022-11-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-05
Last Update Post Date:
2023-12-08
Last Update Post Date Type:
ACTUAL